MILLENNIUM MANAGEMENT LLC

Position in VTRS — Viatris Inc

CIK 1273087 NEW YORK, NY

Back to VTRS Full portfolio

Position in VTRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$37,350,529

-$38,185,164 QoQ

Shares Held

2,764,658

-54.4% QoQ

Ownership

0.237%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

22 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Derivatives in VTRS

reported options exposure · as of Jun 30, 2025

CallValue

$2,232,500

CallShares

250,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $1,135,897,995 across 44 Drug Manufacturers - Specialty & Generic names. VTRS ranks #9 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,649,955	$195,041,180
2	SUPN	Supernus Pharmaceuticals, Inc.	3,315,973	$171,402,644
3	NBIX	Neurocrine Biosciences Inc	1,247,447	$164,338,667
4	INDV	Indivior Pharmaceuticals, Inc.	4,595,535	$140,071,906
5	UTHR	UNITED THERAPEUTICS Corp	153,372	$90,946,528
6	TEVA	Teva Pharmaceutical Industries Ltd	1,893,845	$57,042,611
7	PRGO	PERRIGO Co plc	4,279,731	$45,964,310
8	ANIP	Ani Pharmaceuticals Inc	592,013	$45,525,799

All Filings in VTRS

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$37,350,529	2,764,658	-54.4%	Shares	Sole	2026-05-15
2025-12-31	$75,535,693	6,067,124	-11.3%	Shares	Sole	2026-02-17
2025-09-30	$67,740,750	6,842,500	-10.8%	Shares	Sole	2025-11-14
2025-06-30	$68,520,300	7,673,046	+2969.2%	Shares	Sole	2025-08-14
2025-06-30	$2,232,500	250,000	-7.4%	Call	Sole	2025-08-14
2025-03-31	$2,350,829	269,900	-91.8%	Put	Sole	2025-05-15
2025-03-31	$28,700,321	3,295,100	+998.4%	Shares	Sole	2025-05-15
2025-03-31	$2,613,000	300,000	-92.0%	Call	Sole	2025-05-15
2024-12-31	$46,890,646	3,766,317	-38.8%	Shares	Sole	2025-02-14
2024-09-30	$71,428,133	6,152,294	+2976.1%	Shares	Sole	2024-11-14
2024-06-30	$2,126,000	200,000	-73.4%	Call	Sole	2024-08-14
2024-06-30	$7,985,256	751,200	+200.5%	Shares	Sole	2024-08-14
2024-03-31	$2,985,000	250,000	-38.0%	Call	Sole	2024-05-15
2024-03-31	$4,811,223	402,950	+26.9%	Shares	Sole	2024-05-15
2023-12-31	$3,438,752	317,521	-76.6%	Shares	Sole	2024-02-14
2023-09-30	$13,400,824	1,359,110	+4094.8%	Shares	Sole	2023-11-14
2023-06-30	$323,352	32,400	-99.2%	Put	Sole	2023-08-14
2023-06-30	$40,655,685	4,073,716	+1933.8%	Shares	Sole	2023-08-14
2023-03-31	$1,926,886	200,300	+257.7%	Put	Sole	2023-05-15
2023-03-31	$538,720	56,000	-90.3%	Call	Sole	2023-05-15
2023-03-31	$5,534,424	575,304	+30.5%	Shares	Sole	2023-05-15
2022-12-31	$4,907,217	440,900	-10.3%	Put	Sole	2023-02-14
2022-12-31	$5,468,169	491,300	-90.6%	Call	Sole	2023-02-14
2022-12-31	$57,905,216	5,202,625	-31.2%	Shares	Sole	2023-02-14
2022-09-30	$64,408,388	7,559,670	+873.8%	Shares	Sole	2022-11-14
2022-09-30	$6,614,076	776,300	+533.7%	Put	Sole	2022-11-14
2022-09-30	$1,043,700	122,500	-81.4%	Call	Sole	2022-11-14
2022-06-30	$6,892,474	658,307	-15.4%	Shares	Sole	2022-08-15
2022-06-30	$8,145,660	778,000	+526.4%	Put	Sole	2022-08-15
2022-06-30	$1,300,374	124,200	-78.8%	Call	Sole	2022-08-15
2022-03-31	$6,383,045	586,677	-68.7%	Shares	Sole	2022-05-16
2021-12-31	$25,396,283	1,877,035	-47.1%	Shares	Sole	2022-02-14
2021-09-30	$48,103,570	3,550,079	+191.6%	Shares	Sole	2021-11-15
2021-06-30	$17,398,789	1,217,550	+453.4%	Shares	Sole	2021-08-16
2021-03-31	$3,073,400	220,000	-85.4%	Call	Sole	2021-05-17
2021-03-31	$21,072,850	1,508,436	-32.3%	Shares	Sole	2021-05-17
2020-12-31	$41,744,343	2,227,553	+791.0%	Shares	Sole	2021-02-16
2020-12-31	$4,685,000	250,000	—	Call	Sole	2021-02-16
No filing history on record for this holder in this stock.